Real-World Results from Talquetamab and Bispecific Antibodies | Carolina Schinke, MD | ASH 2023

Interview with Carolina Schinke, MD from University of Arkansas for Medical Sciences at ASH 2023. Filmed December 9, 2023.

ASH ABSTRACT:
Updated Results of Talquetamab, a GPRC5D×CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma with Prior Exposure to T-Cell Redirecting Therapies: Results of the Phase 1/2 MonumenTAL-1 Study
https://ash.confex.com/ash/2023/webpr...

The HealthTree Foundation for Multiple Myeloma brings information from the experts to the patients! Learn more at https://www.healthtree.org/myeloma/co...

Donate to the HealthTree Foundation for Multiple Myeloma or learn more about additional myeloma support we offer here: https://give.healthtree.org/campaign/...

HealthTree Cure Hub helps you find your best treatment options and accelerate a cure for multiple myeloma. Join today at https://www.healthtree.org/

Follow HealthTree:
twitter.com/healthtreeformm
facebook.com/healthtreeformultiplemyeloma
instagram.com/healthtreeformultiplemyeloma